Bioresorbable vascular scaffold (BVS) use in clinical practice for the treatment of coronary lesions has expanded rapidly since they became commercially available. Recently, reports of clinical outcomes with BVS in a broader, more complex “real-world” patient population have started to emerge1-3.
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? / Foin, Nicolas; Torii, Ryo; Mattesini, Alessio; Wong, Philip; Di Mario, Carlo. - In: EUROINTERVENTION. - ISSN 1774-024X. - ELETTRONICO. - 10:(2015), pp. 1139-1142. [10.4244/EIJY14M11_09]
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events?
Mattesini, Alessio;Di Mario, Carlo
2015
Abstract
Bioresorbable vascular scaffold (BVS) use in clinical practice for the treatment of coronary lesions has expanded rapidly since they became commercially available. Recently, reports of clinical outcomes with BVS in a broader, more complex “real-world” patient population have started to emerge1-3.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
